EXHIBIT 23.2

Reed Smith

Nanette W. Mantell
Direct Phone: +1 609 514 8542
Email: nmantell@reedsmith.com Reed Smith LLP
Princeton Forrestal Village
136 Main Street — Suite 250
Princeton, NJ 08540-7839
+1 609 987 0050
Fax +1 609 951 0824
www.reedsmith.com

May 16, 2008

U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549

     Re:            DUSA Pharmaceuticals, Inc. (“DUSA”) Registration Statement on Form S-3

Ladies and Gentlemen:

     We consent to the reference to our firm’s name under the heading “Legal Matters” in DUSA’s Registration Statement on Form S-3, as filed with the Securities and Exchange Commission (the “Commission”) on this date, pursuant to the Securities Act of 1933, as amended, which is being filed with the Commission in connection with the registration of up to $75,000,000 of the DUSA’s common stock, preferred stock, debt securities, depository shares and warrants. In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.

Very truly yours,

/s/ Reed Smith LLP

REED SMITH LLP

NEW YORK • LONDON • HONG KONG • CHICAGO • WASHINGTON, D.C. • BEIJING • PARIS • LOS ANGELES • SAN FRANCISCO • PHILADELPHIA • PITTSBURGH
OAKLAND • MUNICH • ABU DHABI • PRINCETON • NORTHERN VIRGINIA • WILMINGTON • BIRMINGHAM • DUBAI • CENTURY CITY • RICHMOND • GREECE